Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
End Point Considerations for Clinical Trials in Enteric Hyperoxaluria.
Langman CB, Assimos D, Blank M, Calle J, Grauer A, Kausz A, Milliner D, Nazzal L, Smith K, Tasian G, Thompson A, Wood KD, Worcester E, Yang S, Malley MA, Knauf F, Lieske JC; Rare Kidney Stone Consortium (RKSC) Kidney Health Initiative (KHI) Oxalosis and Hyperoxaluria Foundation Enteric Hyperoxaluria Workgroup (OHF EH Workgroup). Langman CB, et al. Among authors: kausz a. Clin J Am Soc Nephrol. 2023 Dec 1;18(12):1637-1644. doi: 10.2215/CJN.0000000000000234. Epub 2023 Jun 21. Clin J Am Soc Nephrol. 2023. PMID: 37342976
Pathophysiology and Treatment of Enteric Hyperoxaluria.
Witting C, Langman CB, Assimos D, Baum MA, Kausz A, Milliner D, Tasian G, Worcester E, Allain M, West M, Knauf F, Lieske JC. Witting C, et al. Among authors: kausz a. Clin J Am Soc Nephrol. 2021 Mar 8;16(3):487-495. doi: 10.2215/CJN.08000520. Epub 2020 Sep 8. Clin J Am Soc Nephrol. 2021. PMID: 32900691 Free PMC article.
Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy.
Thompson A, Carroll K, A Inker L, Floege J, Perkovic V, Boyer-Suavet S, W Major R, I Schimpf J, Barratt J, Cattran DC, S Gillespie B, Kausz A, W Mercer A, Reich HN, H Rovin B, West M, Nachman PH. Thompson A, et al. Among authors: kausz a. Clin J Am Soc Nephrol. 2019 Mar 7;14(3):469-481. doi: 10.2215/CJN.08600718. Epub 2019 Jan 11. Clin J Am Soc Nephrol. 2019. PMID: 30635299 Free PMC article.
Safety of ferumoxytol in patients with anemia and CKD.
Singh A, Patel T, Hertel J, Bernardo M, Kausz A, Brenner L. Singh A, et al. Among authors: kausz a. Am J Kidney Dis. 2008 Nov;52(5):907-15. doi: 10.1053/j.ajkd.2008.08.001. Epub 2008 Sep 27. Am J Kidney Dis. 2008. PMID: 18824288 Clinical Trial.
Ferumoxytol for treating iron deficiency anemia in CKD.
Spinowitz BS, Kausz AT, Baptista J, Noble SD, Sothinathan R, Bernardo MV, Brenner L, Pereira BJ. Spinowitz BS, et al. Among authors: kausz at. J Am Soc Nephrol. 2008 Aug;19(8):1599-605. doi: 10.1681/ASN.2007101156. Epub 2008 Jun 4. J Am Soc Nephrol. 2008. PMID: 18525001 Free PMC article. Clinical Trial.
48 results